Recent AD research has established that significant Aβ accumulation has already occurred at the prodromal stage of AD, known as mild cognitive impairment (MCI) due to AD, followed by the spreading of abnormal tau protein to parietotemporal areas in the cerebral cortices [4,5]. The gene discussed is MAPT; the disease is Alzheimer disease.